Chick Corea, the Master Mixer of Jazz’s Past and Future
|

Chick Corea, the Master Mixer of Jazz’s Past and Future

When the groundbreaking pianist Chick Corea died unexpectedly, at 79, in February 2021, he left a legacy of experimentation, preserving and expanding the jazz tradition. Over more than a half-century, he deftly navigated the music’s continually shifting boundaries. Corea started his career playing with the Afro-Cuban percussionist Willie Bobo and…

Misty Copeland on ‘Serenade,’ Democracy and the Art of Movement
|

Misty Copeland on ‘Serenade,’ Democracy and the Art of Movement

SERENADE A Balanchine Story By Toni Bentley Toni Bentley’s sixth book, “Serenade,” is a tribute not only to the Georgian American choreographer George Balanchine’s timeless, titular ballet, but also to the art form. Bentley, who danced under Balanchine’s direction at the New York City Ballet for a decade in the…

Live Updates: Subway Gunman Is Still at Large as New Yorkers Begin Commute
|

Live Updates: Subway Gunman Is Still at Large as New Yorkers Begin Commute

Teachers in Sunset Park on Tuesday said classes went on as usual, but were preparing themselves for difficult conversations the next day.Credit…Hilary Swift for The New York Times For Shahana Ghosh, a first-grade teacher at P.S. 24 in Sunset Park, just two blocks from the subway station where Tuesday’s shooting…

McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulators
|

McKinsey Opened a Door in Its Firewall Between Pharma Clients and Regulators

Jeff Smith, a partner with the influential consulting firm McKinsey & Company, accepted a highly sensitive assignment in December 2017. The opioid manufacturer Purdue Pharma, beleaguered and in financial trouble, wanted to revamp its business, and an executive there sought out Dr. Smith. Over the following weeks, he traveled to…

Opinion | Why Experts Can’t Seem to Agree on Boosters
|

Opinion | Why Experts Can’t Seem to Agree on Boosters

And about that data: Everyone wishes they were stronger. While some regard the research out of Israel as sufficient to back a second booster, Dr. Borio sees methodological shortcomings that limit its usefulness in shaping public policy decisions. “Understandably, these sorts of population-wide observational studies aren’t randomized, they’re not taking…